Illness	Number of cases
Hyperplasia of prostate (N40)	439
Malignant neoplasm of prostate (C61)	222
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	185
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	112
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	90
Obstructive and reflux uropathy (N13.3)	59
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	50
Calculus of kidney and ureter - Calculus of kidney (N20.0)	47
Calculus of kidney and ureter - Calculus of ureter (N20.1)	46
Bacterial infection of unspecified site - Other bacterial infections of unspecified site (A49.8)	36

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	1.051
Surgical removal or destruction of prostatic tissue through the urethra (5-601.72)	539
Insertion, exchange or removal of a ureteral stent (8-137.00)	289
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	241
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	241
Computed tomography of the abdomen with contrast medium (3-225)	206
Insertion, exchange or removal of a ureteral stent (8-137.10)	195
(9-984.7)	145
(9-984.8)	114
Removal of stones, foreign bodies or collections of blood from the bladder by endoscopy (5-570.4)	101

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2291

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
66	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
24	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
24	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Lectureships / teaching posts at colleges and universities
Doctoral supervision
Participation in multi-centre phase III/IV studies

Training

No.	Training in other healing professions	Comment
HB15	Anaesthesia technical assistant (m/f)
HB17	Auxiliary nurse (m/f)
HB21	Geriatric nurse (m/f)
HB19	Nursing professionals
HB07	Surgical technical assistant (m/f)
HB18	Emergency paramedics (m/f) (training period 3 years)	Nur im Rahmen der praktischen Einsätze.
HB01	Nurse and health care worker (m/f)